Skip to main content

Table 1 A comparison of selected clearing methods in the mammary gland

From: Imaging the mammary gland and mammary tumours in 3D: optical tissue clearing and immunofluorescence methods

Method

Method overview

RI

Clearing capability

Durationa

Preservation

Whole mount IHC

Long-term storage

Rehydration and sectioning

Reference

structure

FP

Uncleared

No clearing protocol applied

−

−

1 day

Preserved

Preserved

Compatible

No

Possiblef

−

3DISCO

Organic solvent-based

1.56

Strong

2 days

Compromised

Rapid loss

Difficultc

No

Not possible

[8]

PACT-RC

Aqueous solution-based (hydrogel embedding)

1.45

Weak

10 days

Preserved, mild expansion

Preserved

Compatible

Yes

Not possible

[11]

PACT-sRIMS

Aqueous solution-based (hydrogel embedding)

1.46

Weak

13 days

Preserved

Preserved

Compatible

No

Possiblef

[11]

CUBIC

Aqueous solution-based (simple immersion)

1.48–9

Strong

5 days

Preserved, mild expansion

Some lossb

Semi-compatibled

No

Confirmed

[10]

SeeDB

Aqueous solution-based (simple immersion)

1.49

Moderate

5 days

Preserved, mild shrinkage

Preserved

Compatible

Noe

Confirmed

[9]

  1. aDuration from the time of tissue harvest (includes fixation time typically 6–16 h for mammary tissue). bAs previously reported [10, 39] and the observed requirement for slightly higher laser power for confocal imaging. This may be improved by using the second generation protocol (using Reagent 1A). cUsing the three-dimensional imaging of solvent-cleared organs combined with optimised whole-mount immunolabelling procedures iDISCO/three-dimensional imaging of solvent-cleared organs (3DISCO) method. The fluorescence signal is rapidly quenched using benzyl alcohol benzyl benzoate (BABB) and a specialised imaging chamber is required for dibenzyl ether (DBE). dSome antibodies (i.e. E-cadherin, K8 and human epidermal growth factor receptor 2) do not perform as well as in other clearing protocols. eOptimally imaged within 2 weeks but may be stored for several months. fLikely to be compatible, but not tested in this study. RI refractive index, FP fluorescent protein, IHC immunohistochemical analysis, PACT-RC passive clarity technique-Rapiclear, sRIMS sorbitol refractive index matching solution, CUBIC clear unobstructed brain imaging cocktails, SeeDB see deep brain